Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman

Patient: Female, 28-year-old Final Diagnosis: Cerebral venous sinus thrombosis (CVST) post first dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine Symptoms: Headache Medication:— Clinical Procedure: CTV • Laboratory Specialty: Hematology • Immunology • Infectious Diseases • Neurology OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhashim, Ali, Hadhiah, Kawther, khalifah, Zahra Al, Alhaddad, Fatimah Mohammed, Al ARhain, Sara A., Bin Saif, Faisal H., Abid, Ahmad, Gamdi, Omar Al, Alsulaiman, Feras, AlQarni, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842441/
https://www.ncbi.nlm.nih.gov/pubmed/35136010
http://dx.doi.org/10.12659/AJCR.934744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842441/
https://www.ncbi.nlm.nih.gov/pubmed/35136010
http://dx.doi.org/10.12659/AJCR.934744

Ejemplares similares